Compounds > golotimod

golotimod and Tuberculosis

golotimod has been researched along with Tuberculosis* in 3 studies

Reviews

1 review(s) available for golotimod and Tuberculosis

ArticleYear
SCV-07 (SciClone Pharmaceuticals/Verta).
    Current opinion in investigational drugs (London, England : 2000), 2006, Volume: 7, Issue:2

    SciClone Pharmaceuticals and Verta are developing SCV-07, the lead in a series of immnunostimulants from Verta, for the potential treatment of tuberculosis and hepatitis C virus infection. Phase II clinical trials of the compound are ongoing.

    Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Antiviral Agents; Clinical Trials as Topic; Dipeptides; Drug Administration Schedule; Drug Evaluation, Preclinical; Hepatitis C, Chronic; Humans; Injections, Intramuscular; Lassa virus; Mycobacterium tuberculosis; Papillomaviridae; Spleen; Thymus Gland; Tuberculosis

2006

Other Studies

2 other study(ies) available for golotimod and Tuberculosis

ArticleYear
Immune system stimulator shows promise against tuberculosis.
    The Lancet. Infectious diseases, 2002, Volume: 2, Issue:12

    Topics: Adjuvants, Immunologic; Animals; Antitubercular Agents; Clinical Trials, Phase II as Topic; Dipeptides; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immune System; Injections, Intramuscular; Mice; Russia; Tuberculosis

2002
Cold war adversaries team up to conquer TB.
    Drug discovery today, 2002, Dec-01, Volume: 7, Issue:23

    Topics: Clinical Trials as Topic; Dipeptides; Humans; Tuberculosis; United States; USSR

2002